Williford WO - Search Results

1

Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial. VA Cooperative Study Group on Gastroesophageal Reflux Disease (GERD).

Williford WO, Krol WF, Spechler SJ. Williford WO, et al. Control Clin Trials. 1994 Oct;15(5):335-48. doi: 10.1016/0197-2456(94)90031-0. Control Clin Trials. 1994. PMID: 8001355 Clinical Trial.

2

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W. Spechler SJ, et al. JAMA. 2001 May 9;285(18):2331-8. doi: 10.1001/jama.285.18.2331. JAMA. 2001. PMID: 11343480 Clinical Trial.

3

Comparison of eligible randomized patients with two groups of ineligible patients: can the results of the VA Total Parenteral Nutrition clinical trial be generalized?

Williford WO, Krol WF, Buzby GP. Williford WO, et al. J Clin Epidemiol. 1993 Sep;46(9):1025-34. doi: 10.1016/0895-4356(93)90170-6. J Clin Epidemiol. 1993. PMID: 8263575 Clinical Trial.

4

Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group.

Kim SL, Waring JP, Spechler SJ, Sampliner RE, Doos WG, Krol WF, Williford WO. Kim SL, et al. Among authors: williford wo. Gastroenterology. 1994 Oct;107(4):945-9. Gastroenterology. 1994. PMID: 7926484

5

The effects of antireflux therapy on pulmonary function in patients with severe gastroesophageal reflux disease. Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group.

Spechler SJ, Gordon DW, Cohen J, Williford WO, Krol W. Spechler SJ, et al. Among authors: williford wo. Am J Gastroenterol. 1995 Jun;90(6):915-8. Am J Gastroenterol. 1995. PMID: 7771420 Clinical Trial.

6

The "constant intake rate" assumption in interim recruitment goal methodology for multicenter clinical trials.

Williford WO, Bingham SF, Weiss DG, Collins JF, Rains KT, Krol WF. Williford WO, et al. J Chronic Dis. 1987;40(4):297-307. doi: 10.1016/0021-9681(87)90045-2. J Chronic Dis. 1987. PMID: 3558706

7

Significance: clinical or statistical?

Bingham SF, Collins JF, Weiss DG, Williford WO, Krol WF. Bingham SF, et al. Among authors: williford wo. Thromb Haemost. 1989 Apr 25;61(2):323-5. Thromb Haemost. 1989. PMID: 2749605 No abstract available.

8

Overview of the DIG trial.

Collins JF, Egan D, Yusuf S, Garg R, Williford WO, Geller N; DIG Investigators. Collins JF, et al. Among authors: williford wo. Control Clin Trials. 2003 Dec;24(6 Suppl):269S-276S. doi: 10.1016/s0197-2456(03)00104-1. Control Clin Trials. 2003. PMID: 14643073

9

The role of the data coordinating center in the DIG trial.

Williford WO, Collins JF, Horney A, Kirk G, McSherry F, Spence E, Stinnett S, Howell CL, Garg R, Egan D, Yusuf S; DIG Investigators. Williford WO, et al. Control Clin Trials. 2003 Dec;24(6 Suppl):277S-288S. doi: 10.1016/s0197-2456(03)00103-x. Control Clin Trials. 2003. PMID: 14643074

10

The role of the pharmacy coordinating center in the DIG trial.

Fye CL, Gagne WH, Raisch DW, Jones MS, Sather MR, Buchanan SL, Chacon FR, Garg R, Yusuf S, Williford WO; DIG Investigators. Fye CL, et al. Among authors: williford wo. Control Clin Trials. 2003 Dec;24(6 Suppl):289S-297S. doi: 10.1016/s0197-2456(03)00102-8. Control Clin Trials. 2003. PMID: 14643075

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page